Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP883092.RAgRSSeDtn-5-ufPys5mnHBKtaJLWWiqL0Ve3419rv0pE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP883092.RAgRSSeDtn-5-ufPys5mnHBKtaJLWWiqL0Ve3419rv0pE130_assertion type Assertion NP883092.RAgRSSeDtn-5-ufPys5mnHBKtaJLWWiqL0Ve3419rv0pE130_head.
- NP883092.RAgRSSeDtn-5-ufPys5mnHBKtaJLWWiqL0Ve3419rv0pE130_assertion description "[In particular, ASXL1 mutations are common in patients with hematologic malignancies associated with myelodysplasia, including myelodysplastic syndromes (MDSs), and chronic myelomonocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP883092.RAgRSSeDtn-5-ufPys5mnHBKtaJLWWiqL0Ve3419rv0pE130_provenance.
- NP883092.RAgRSSeDtn-5-ufPys5mnHBKtaJLWWiqL0Ve3419rv0pE130_assertion evidence source_evidence_literature NP883092.RAgRSSeDtn-5-ufPys5mnHBKtaJLWWiqL0Ve3419rv0pE130_provenance.
- NP883092.RAgRSSeDtn-5-ufPys5mnHBKtaJLWWiqL0Ve3419rv0pE130_assertion SIO_000772 24216483 NP883092.RAgRSSeDtn-5-ufPys5mnHBKtaJLWWiqL0Ve3419rv0pE130_provenance.
- NP883092.RAgRSSeDtn-5-ufPys5mnHBKtaJLWWiqL0Ve3419rv0pE130_assertion wasDerivedFrom befree-20140225 NP883092.RAgRSSeDtn-5-ufPys5mnHBKtaJLWWiqL0Ve3419rv0pE130_provenance.
- NP883092.RAgRSSeDtn-5-ufPys5mnHBKtaJLWWiqL0Ve3419rv0pE130_assertion wasGeneratedBy ECO_0000203 NP883092.RAgRSSeDtn-5-ufPys5mnHBKtaJLWWiqL0Ve3419rv0pE130_provenance.